You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood glioblastoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
Has Results
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Oct 3, 2023

Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Feb 20, 2023

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Glioblastoma Trial (plasma collection)

Not yet recruiting
  • Glioblastoma
  • plasma collection
  • (no location specified)
Aug 18, 2023

Glioblastoma Trial (Tislelizumab and Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Tislelizumab and Bevacizumab
  • (no location specified)
Apr 12, 2023

Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Recurrent Glioblastoma
  • Pitavastatin calcium
  • Rotterdam, Netherlands
    Erasmus MC
Aug 3, 2023

Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

Not yet recruiting
  • Recurrent Glioblastoma
  • Sintilimab plus Bevacizumab and Temozolomide
  • (no location specified)
Nov 27, 2022

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

Not yet recruiting
  • Recurrent Glioblastoma
  • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
  • +2 more
  • Brussels, Belgium
    UZ Brussel
Oct 23, 2023

Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Dec 23, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Glioblastoma Trial (Tofacitinib 5 MG)

Recruiting
  • Glioblastoma
  • Tofacitinib 10mg
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 3, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • Hangzhou, Zhejiang, China
  • +2 more
Dec 25, 2022

Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

Recruiting
  • Glioblastoma
  • Glioblastoma, IDH-wildtype
  • Biomolecular tumor analysis
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022